Analytics

Robert Booker, chief strategy officer at HITRUST, discusses how the company is adjusting its risk and data management guidance for healthcare providers to ensure cybersecurity after the emergence of new threats posed by genAI in society.

QuantHealth cofounder and CEO Orr Inbar discusses how using artificial intelligence for clinical trial simulations can help solve challenges often seen by patients, researchers and the pharmaceutical industry when studying a new drug.

Digital health companies need to think about what will happen 10 to 15 years from now to create strategies that ensure growth and longevity, says Dr. Guido Giunti, adjunct professor of digital health at the University of Oulu in Finland.

ShiftMed EVP and chief nurse executive Larry Adams discusses artificial intelligence tools such as predictive analytics, intelligent scheduling and data-driven decision support, and how they can help solve staffing shortages in the nursing field.  

Matt Cybulsky, LBMC practice leader for healthcare AI, value-based care and product innovation, discusses paths to implement digital health tools for value-based care and the advantages of using AI to ease provider workflow.

Children's Health Alliance senior director of population health Julie Harris discusses how real-time performance metrics can give providers more information at the point of care and reduce their burdens.  

Dr. Benoit Desjardins, University of Pennsylvania radiology professor, explains that, because generative AI models employ "shallow thinking," they can't yet explain how they reach conclusions or replicate the way a human doctor thinks.

Hal Wolf, HIMSS president and CEO, discusses the possible influence that conversations at HIMSS24 between international healthcare leaders could have on healthcare technology policy development in the EU and other regions.

Threat actors are increasingly using AI to generate hacking attempts and phishing scams. Jeff Webber, Intelliguard CTO, calls for cybersecurity vendors to create AI-powered solutions to fight these new threats.

Jerry Shultz, Lightbeam Health Solutions' president, says the company's AI identifies COPD patients who need personalized interventions, reducing readmissions and realizing millions of dollars in savings for clients.